Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 204,071 |
|
|||||
| News | - | ||||||
| Day High | 0.23 | Low High |
|||||
| Day Low | 0.2011 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| 60 Degrees Pharmaceuticals Inc | SXTP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.022 | -9.48% | 0.21 | 23:00:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.23 | 0.2011 | 0.23 | 0.21 | 0.232 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 478 | 204,071 | US$ 0.2132796 | US$ 43,524 | - | 0.2011 - 8.65 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:12:27 | 10 | US$ 0.2115 | USD |
60 Degrees Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.22M | 5.80M | - | 254k | -3.77M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
60 Degrees Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SXTP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.242 | 0.245 | 0.2011 | 0.2324255 | 384,345 | -0.032 | -13.22% |
| 1 Month | 0.28 | 0.30 | 0.2011 | 0.241624 | 160,962 | -0.07 | -25.00% |
| 3 Months | 0.267 | 0.357 | 0.2011 | 0.2721219 | 212,948 | -0.057 | -21.35% |
| 6 Months | 0.58 | 1.53 | 0.2011 | 0.787618 | 477,218 | -0.37 | -63.79% |
| 1 Year | 3.75 | 8.65 | 0.2011 | 2.13 | 550,334 | -3.54 | -94.40% |
| 3 Years | 3.75 | 8.65 | 0.2011 | 2.13 | 550,334 | -3.54 | -94.40% |
| 5 Years | 3.75 | 8.65 | 0.2011 | 2.13 | 550,334 | -3.54 | -94.40% |
60 Degrees Pharmaceuticals Description
| 60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older. The Company's pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases; new products that contain the Arakoda regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. The ARAKODA regimen of tafenoquine is in Phase II study data in patients with mild-moderate COVID-19 disease. It is also planning a clinical study to assess the utility of ARAKODA as a treatment for human babesiosis. The Company is also developing Celgosivir for the treatment of COVID-19, respiratory syncytial virus (RSV), and dengue. |
